QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.065383v1 310/3/1199    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woodahl, E. L. Articles by Ho, R. J. Y. Search for Related Content PubMed PubMed Citation Articles by Woodahl, E. L. Articles by Ho, R. J. Y.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein

Department of Pharmaceutics, University of Washington, Seattle, Washington

The significance of the human multidrug resistance gene (MDR1) G1199A polymorphism, resulting in a Ser400Asn modification in P-glycoprotein (P-gp), remains unclear. We have developed stable recombinant LLC-PK1 epithelial cells expressing either MDR1_wt or MDR1₁₁₉₉ to evaluate functional consequences of G1199A [N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide]. P-gp activity observed in MDR1_wt and MDR1₁₁₉₉ cells was completely inhibited in the presence of the specific P-gp inhibitor GF120918. Comparable expression of mRNA and protein in the MDR1-expressed cells and correct localization of P-gp in the apical membrane of recombinant cells was verified. Mean intracellular rhodamine-123 (R123) accumulation, measured by flow cytometry, was approximately 4.75-fold higher in MDR1₁₁₉₉ recombinant cells than MDR1_wt cells. Cytotoxicity studies have shown that MDR1_wt and MDR1₁₁₉₉ cells exhibited similar resistance, as measured by EC₅₀ values, to doxorubicin (155 ± 68 versus 120 ± 32 nM); however, MDR1₁₁₉₉ cells were more resistant to vinblastine (1.41 ± 0.51 versus 15.7 ± 4.0 nM; p < 0.001) and vincristine (1.18 ± 0.56 versus 3.41 ± 1.47 nM; p < 0.05). The apparent transepithelial permeability ratios of R123 in MDR1_wt and MDR1₁₁₉₉ cells were 3.54 ± 0.94 and 2.02 ± 0.51 (p < 0.05), respectively. Therefore, the G1199A polymorphism alters the efflux and transepithelial permeability of a fluorescent substrate and sensitivity to select cytotoxic agents, which may influence drug disposition and therapeutic efficacy of some P-gp substrates.

Address correspondence to: Dr. Rodney J. Y. Ho, Department of Pharmaceutics, Box 357610, University of Washington, Seattle, WA 98195-7610. E-mail: rodneyho{at}u.washington.edu

This article has been cited by other articles:

				Z. Yang, D. Wu, T. Bui, and R. J. Y. Ho A Novel Human Multidrug Resistance Gene MDR1 Variant G571A (G191R) Modulates Cancer Drug Resistance and Efflux Transport J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 474 - 481. [Abstract] [Full Text] [PDF]

				D. Siccardi, K. L. Mumy, D. M. Wall, J. D. Bien, and B. A. McCormick Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1392 - G1400. [Abstract] [Full Text] [PDF]

				J. M. Gow, L. M. Hodges, L. W. Chinn, and D. L. Kroetz Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 435 - 442. [Abstract] [Full Text] [PDF]

				P. Hsiao, T. Bui, R. J. Y. Ho, and J. D. Unadkat In Vitro-to-in Vivo Prediction of P-glycoprotein-Based Drug Interactions at the Human and Rodent Blood-Brain Barrier Drug Metab. Dispos., March 1, 2008; 36(3): 481 - 484. [Abstract] [Full Text] [PDF]